Literature DB >> 35108353

Fetal vs adult megakaryopoiesis.

Patricia Davenport1,2, Zhi-Jian Liu1,2, Martha Sola-Visner1,2.   

Abstract

Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as "immaturity." However, more recent studies have demonstrated that the small, low-ploidy fetal and neonatal megakaryocytes have all the characteristics of adult polyploid megakaryocytes, including the presence of granules, a well-developed demarcation membrane system, and proplatelet formation. Thus, rather than immaturity, the features of fetal and neonatal megakaryopoiesis reflect a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation, which allows fetuses and neonates to populate their rapidly expanding bone marrow and blood volume. At the molecular level, the features of fetal and neonatal megakaryopoiesis are the result of a complex interplay of developmentally regulated pathways and environmental signals from the different hematopoietic niches. Over the past few years, studies have challenged traditional paradigms about the origin of the megakaryocyte lineage in both fetal and adult life, and the application of single-cell RNA sequencing has led to a better characterization of embryonic, fetal, and adult megakaryocytes. In particular, a growing body of data suggests that at all stages of development, the various functions of megakaryocytes are not fulfilled by the megakaryocyte population as a whole, but rather by distinct megakaryocyte subpopulations with dedicated roles. Finally, recent studies have provided novel insights into the mechanisms underlying developmental disorders of megakaryopoiesis, which either uniquely affect fetuses and neonates or have different clinical presentations in neonatal compared with adult life.
© 2022 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2022        PMID: 35108353      PMCID: PMC9164738          DOI: 10.1182/blood.2020009301

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  114 in total

1.  Engagement of integrin alpha4beta1 enhances thrombopoietin-induced megakaryopoiesis.

Authors:  Norma E Fox; Kenneth Kaushansky
Journal:  Exp Hematol       Date:  2005-01       Impact factor: 3.084

2.  Analysis of the human fetal liver hematopoietic microenvironment.

Authors:  Matthew A Martin; Mickie Bhatia
Journal:  Stem Cells Dev       Date:  2005-10       Impact factor: 3.272

3.  Developmental change of megakaryocyte maturation and DNA ploidy in human fetus.

Authors:  D C Ma; Y H Sun; K Z Chang; W Zuo
Journal:  Eur J Haematol       Date:  1996-08       Impact factor: 2.997

4.  Brief Report: Single-Cell Analysis Reveals Cell Division-Independent Emergence of Megakaryocytes From Phenotypic Hematopoietic Stem Cells.

Authors:  Aline Roch; Vincent Trachsel; Matthias P Lutolf
Journal:  Stem Cells       Date:  2015-08-06       Impact factor: 6.277

5.  Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells.

Authors:  Song Chou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

6.  Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation.

Authors:  Fang Jiang; Yuzhi Jia; Isaac Cohen
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

7.  An Outline of the Outset of Thrombopoiesis in Human Embryos At Last.

Authors:  Anna Rita Migliaccio; Ronald Hoffman
Journal:  Cell Stem Cell       Date:  2021-03-04       Impact factor: 24.633

8.  Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment.

Authors:  P Charbord; M Tavian; L Humeau; B Péault
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

9.  Decoding human fetal liver haematopoiesis.

Authors:  Dorin-Mirel Popescu; Rachel A Botting; Emily Stephenson; Kile Green; Simone Webb; Laura Jardine; Emily F Calderbank; Krzysztof Polanski; Issac Goh; Mirjana Efremova; Meghan Acres; Daniel Maunder; Peter Vegh; Yorick Gitton; Jong-Eun Park; Roser Vento-Tormo; Zhichao Miao; David Dixon; Rachel Rowell; David McDonald; James Fletcher; Elizabeth Poyner; Gary Reynolds; Michael Mather; Corina Moldovan; Lira Mamanova; Frankie Greig; Matthew D Young; Kerstin B Meyer; Steven Lisgo; Jaume Bacardit; Andrew Fuller; Ben Millar; Barbara Innes; Susan Lindsay; Michael J T Stubbington; Monika S Kowalczyk; Bo Li; Orr Ashenberg; Marcin Tabaka; Danielle Dionne; Timothy L Tickle; Michal Slyper; Orit Rozenblatt-Rosen; Andrew Filby; Peter Carey; Alexandra-Chloé Villani; Anindita Roy; Aviv Regev; Alain Chédotal; Irene Roberts; Berthold Göttgens; Sam Behjati; Elisa Laurenti; Sarah A Teichmann; Muzlifah Haniffa
Journal:  Nature       Date:  2019-10-09       Impact factor: 69.504

10.  Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis.

Authors:  Shu Sun; Chen Jin; Jia Si; Ying Lei; Kunying Chen; Yueli Cui; Zhenbo Liu; Jiang Liu; Meng Zhao; Xiaohui Zhang; Fuchou Tang; Matthew T Rondina; Yueying Li; Qian-Fei Wang
Journal:  Blood       Date:  2021-10-07       Impact factor: 25.476

View more
  1 in total

1.  Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.

Authors:  Kamaleldin E Elagib; Ashton Brock; Cara M Clementelli; Goar Mosoyan; Lorrie L Delehanty; Ranjit K Sahu; Alexandra Pacheco-Benichou; Corinne Fruit; Thierry Besson; Stephan W Morris; Koji Eto; Chintan Jobaliya; Deborah L French; Paul Gadue; Sandeep Singh; Xinrui Shi; Fujun Qin; Robert Cornelison; Hui Li; Camelia Iancu-Rubin; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2022-10-03       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.